Tany Lynn Herzog

Dr. Tany Lynn Herzog


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
GVGioacchino D De Sario Velasquez
Gioacchino D De Sario Velasquez
YTYousef Tanas
Yousef Tanas
FTFrancesca Taraballi
Francesca Taraballi
THTany Lynn Herzog
Tany Lynn Herzog
ASAldona J. Spiegel
Aldona J. Spiegel
Background: Three-dimensional (3-D) printing paired with tissue-engineering strategies promises to overcome the volume, contour, and donor-site limitations of traditional breast reconstruction. Patient-specific, bioabsorbable constructs could enable one-stage procedures that better restore aesthetics and sensation. Methods: A narrative review was conducted following a targeted PubMed search (inception—April 2025) using combinations of “breast reconstruction,” “tissue engineering,” “3-D printing,” and “scaffold.” Pre-clinical and clinical studies describing polymer-based chambers or scaffolds for breast mound or nipple regeneration were eligible. Data was extracted on scaffold composition, animal/human model, follow-up, and volumetric or histological outcomes. Results: Forty-three publications met inclusion criteria: 35 pre-clinical, six early-phase clinical, and two device reports. The predominant strategy (68% of studies) combined a vascularized fat flap with a custom 3-D-printed chamber to guide adipose expansion. Poly-lactic acid, poly-glyceric acid, poly-lactic-co-glycolic acid, poly-4-hydroxybutyrate, polycarbonate, and polycaprolactone were the principal polymers investigated; only poly-4-hydroxybutyrate and poly-lactic acid have been tested for nipple scaffolds. Bioabsorbable devices supported up to 140% volume gain in large-animal models, but even the best human series (≤18 months) achieved sub-mastectomy volumes and reported high seroma rates. Mechanical testing showed elastic moduli (5–80 MPa) compatible with native breast tissue, yet long-term load-bearing data are scarce. Conclusions: Current evidence demonstrates biocompatibility and incremental adipose regeneration, but clinical translation is constrained by small sample sizes, incomplete resorption profiles, and regulatory uncertainty. Standardized large-animal protocols, head-to-head polymer comparisons, and early human feasibility trials with validated outcome measures are essential next steps. Nevertheless, the convergence of 3-D printing and tissue engineering represents a paradigm shift that could ultimately enable bespoke, single-stage breast reconstruction with superior aesthetic and functional outcomes.

18 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
GVGioacchino D De Sario Velasquez
Gioacchino D De Sario Velasquez
YTYousef Tanas
Yousef Tanas
FTFrancesca Taraballi
Francesca Taraballi
THTany Lynn Herzog
Tany Lynn Herzog
ASAldona J. Spiegel
Aldona J. Spiegel
This review investigates the intersection of tissue engineering and 3D printing technologies in the realm of breast reconstruction, underscoring the transformative potential these approaches offer for enhancing post-mastectomy outcomes. It encompasses a detailed examination of current methodologies, focusing on the creation of biocompatible, bioabsorbable scaffolds that adeptly mimic the extracellular matrix to promote tissue integration and regeneration. A significant portion of the analysis draws from a search conducted on PubMed, which aimed to collate relevant preclinical and clinical studies in this domain. This search underscored the nascent stage of many applications, highlighting a critical need for more comprehensive preclinical trials to validate the efficacy and safety of these innovative solutions. Our search revealed that many studies have studied alternatives for breast reconstruction using tissue engineering; with a significant proportion of these modalities focusing on using flaps inside 3D-printed chambers. Moreover, although some studies have shown significant adipose tissue growth, their results still do not approximate breast dimensions. Specifically, the review identifies a limited range of polymers that have been explored in preclinical and clinical studies for breast reconstruction, including tissue-engineering chambers and scaffolds for the reconstruction of the breast mound made of poly-lactic acid, poly-glycolic acid, poly-lactic-co-glycolic acid, poly-4-hydroxybutyrate, polycarbonate, and polycaprolactone. For nipple reconstruction, two studies assessed scaffolds made of poly-4-hydroxybutyrate and poly-lactic acid. The review highlights the utilization of bioabsorbable materials in these devices, indicating the potential for performing one-stage surgeries. Moreover, it elaborates on the biomechanical properties of these materials, aligning them with the specific goals of breast reconstruction. The review acknowledges the complexity of navigating regulatory landscapes, suggesting that overcoming these obstacles is essential for clinical translation. Despite these challenges, the convergence of 3D printing and tissue engineering is presented as a paradigm shift in breast reconstruction, offering the potential to significantly enhance aesthetic and functional outcomes, minimize post-surgical complications, and improve patients' quality of life.